Myocardial Infarction

FDA clearance granted to market defibrillator

Published in Cardiovascular Week, September 1st, 2003

Cardiac Science, Inc., (DFIB) announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its new Powerheart AED G3 (automated external defibrillator), designed for use by lay persons and trained professionals in the corporate, public access, municipal, home and medical markets.

The new G3 AED product line costs approximately 30% less to produce than Cardiac Science's current model and the company expects the higher gross margins to translate directly into operating profits.

Cardiac Science president and CEO Raymond W. Cohen said, "We will begin immediate shipments to end users, distributors and OEM...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Week

Source: Cardiovascular Week (2003-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry